Will the project "DeNAT: Decentralized production of Nucleic Acid Amplification Test (NAT) throughout the collaborative manufacturing of open source hardware and diagnostic reagents." receive any funding from the Clearer Thinking Regranting program run by ClearerThinking.org?

Below, you can find some selected quotes from the public copy of the application. The text beneath each heading was written by the applicant. Alternatively, you can click here to see the entire public portion of their application.

Project Activities

We have established an open-source NAT production and technology transfer network composed of academic institutions, SMEs and non-profit organizations based across six countries and three continents (Cameroon, Chile (not a core partner for this project), Ghana, France, Switzerland, United Kingdom). 

Building on this foundation, we propose undertaking the following activities:

1. DEVELOP: establish a diagnostic kit including reagents and a readout device that will be transferable and scalable to any target. Our technology of choice is real-time loop-mediated isothermal amplification (LAMP), which has revealed its potential for rapid diagnosis of neglected diseases. One of its greatest strengths is combining the precision of the gold standard in nucleic acid detection, qPCR, and the speed, simplicity and infrastructure independence of rapid antigen testing.

2. ADAPT: demonstrate the ability of the technology to be rapidly adapted to target animal, human or plant infectious diseases that generate large economical burdens in LMICs (e.g., future pandemics and endemics), in addition to targets already established within the project team (SARS-CoV-2, agricultural fungal pests, genetically modified organisms). 

3. SHARE: support the establishment of local diagnostic kit manufacturers that can connect to our growing network, perform field testing and work with the local regulatory authorities to certify the local products by establishing a quality management system framework and guidance as well as templates, protocols and training. 

4. DERISK: consolidate and extend existing market research and demand forecasting to identify investable disease targets for local manufacturers, focused initially on Ghana and the African regional market.

How much funding are they requesting?

$481,917.50

What would they do with the amount specified?

Beneficial Bio: $171,000.00

Duplex Biosciences: $101,000.00

Gaudilabs: $449,320.00

Learning Planet Institute: $70,610.00

Mboalab Biotech: $89,987.50

TOTAL: $481,917.50

Here you can review the entire public portion of the application (which contains a lot more information about the applicant and their project):

https://docs.google.com/spreadsheets/d/1ta9HlSL8mGWrdMpHpnzgFOb8NaL8P-_BQABhq9SbAz8/edit#gid=0

Sep 19, 5:06pm: Will we fund ""? → Will we fund "Decentralized Nucleic Acid Amplification Tests"?